SEC
SlamSEC
Search
Browse
Earnings
Generate Biomedicines, Inc.
Nasdaq:
GENB
Pharmaceutical Preparations
·
SOMERVILLE, MA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
All Filings
(42 total)
Current Reports
Registrations
Insider Activity
All
3
4
424B4
8-A12B
8-K
CERT
DRS
EFFECT
S-1
S-1/A
S-8
Type
Date
Accession
Period
Size
4
Mar 6, 2026
0001193125-26-096799
4
Mar 4, 2026
6.2 KB
4
Mar 2, 2026
0001193125-26-085952
4
Feb 26, 2026
5.1 KB
4
Mar 2, 2026
0001193125-26-085939
4
Feb 26, 2026
6.7 KB
4
Mar 2, 2026
0001193125-26-085928
4
Feb 26, 2026
5.0 KB
4
Mar 2, 2026
0001193125-26-085911
4
Feb 26, 2026
5.2 KB
4
Mar 2, 2026
0001193125-26-085910
4
Feb 26, 2026
5.2 KB
4
Mar 2, 2026
0001193125-26-085903
4
Feb 26, 2026
5.1 KB
4
Mar 2, 2026
0001193125-26-085898
4
Feb 26, 2026
11.8 KB
4
Mar 2, 2026
0001193125-26-085888
4
Feb 26, 2026
55.6 KB
4
Mar 2, 2026
0001193125-26-085886
4
Feb 26, 2026
7.4 KB
4
Mar 2, 2026
0001193125-26-085883
4
Feb 26, 2026
13.0 KB
4
Mar 2, 2026
0001193125-26-085881
4
Feb 26, 2026
10.1 KB
4
Mar 2, 2026
0001193125-26-085872
4
Feb 26, 2026
6.4 KB
4
Mar 2, 2026
0001193125-26-085871
4
Feb 26, 2026
5.1 KB
4
Mar 2, 2026
0001193125-26-085861
4
Feb 26, 2026
5.0 KB
4
Mar 2, 2026
0001193125-26-085855
4
Feb 26, 2026
53.7 KB
8-K
Mar 2, 2026
0001193125-26-085780
8-K
Feb 26, 2026
468.2 KB
S-8
Feb 27, 2026
0001193125-26-083253
S-8
—
293.6 KB
424B4
Feb 27, 2026
0001193125-26-083190
424B4
—
49.1 MB
EFFECT
Feb 26, 2026
9999999995-26-000677
—
1.7 KB
3
Feb 26, 2026
0001193125-26-078748
3
Feb 26, 2026
33.6 KB
3
Feb 26, 2026
0001193125-26-078738
3
Feb 26, 2026
31.5 KB
3
Feb 26, 2026
0001193125-26-078483
3
Feb 26, 2026
25.2 KB
3
Feb 26, 2026
0001193125-26-078427
3
Feb 26, 2026
21.4 KB
3
Feb 26, 2026
0001193125-26-078419
3
Feb 26, 2026
19.9 KB
25 filings shown
Generate Biomedicines, Inc. — SlamSEC